Storage Condition
Refer MSDS for complete information
Synonyms
Enzalutamide Impurity B
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
N,N'-Bis[3-(trifluoromethyl-4-cyanophenyl)thiourea is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
N,N'-Bis[3-(trifluoromethyl-4-cyanophenyl)thiourea usage and description
N,N'-Bis[3-(trifluoromethyl-4-cyanophenyl)thiourea, also known as BCTC, is a synthetic compound that has been widely used in scientific research for its ability to modulate the activity of a specific group of ion channels known as TRPM8 channels. These channels are primarily found in the peripheral nervous system and play a crucial role in the regulation of body temperature, pain perception, and cold sensation.
BCTC has been shown to selectively block TRPM8 channels, thereby reducing the sensitivity of nerve fibers to cold temperatures and decreasing the perception of cold-induced pain. As a result, BCTC has potential therapeutic applications in the treatment of chronic pain conditions such as neuropathic pain and cold allodynia.
From a chemical perspective, BCTC is a thiourea derivative that contains two aromatic rings substituted with trifluoromethyl and cyano groups. This unique structure allows BCTC to bind to specific sites on TRPM8 channels, thereby blocking their activity.
While BCTC has shown promising results in preclinical studies, its potential therapeutic applications in humans are still under investigation. As with any new drug, further research is needed to fully understand its mechanisms of action, potential side effects, and optimal dosing regimens.
